Back to GetFilings.com



Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended December 31, 2002

 

¨   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                      to                      .

 

Commission file number 000-23783

 


 

MICROMUSE INC.

(Exact name of registrant as specified in its charter)

 

DELAWARE

 

94-3288385

(State or other jurisdiction of

 

(IRS Employer

incorporation or organization)

 

Identification No.)

 

139 TOWNSEND STREET

SAN FRANCISCO, CALIFORNIA 94107

(415) 538-9090

(Address, including ZIP code, and telephone number)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in rule 12b-2 of the Exchange Act).  Yes  ¨  No  x

 

74,969,725 shares of Common Stock, $0.01 par value, were outstanding as of January 31, 2003

 



Table of Contents

MICROMUSE INC.

 

TABLE OF CONTENTS

 

    

Page


PART I—Financial Information

    

Item 1.

  

Condensed Consolidated Financial Statements:

    
    

Condensed Consolidated Balance Sheets as of December 31, 2002 and September 30, 2002

  

3

    

Condensed Consolidated Statements of Operations for the three months ended December 31, 2002 and 2001

  

4

    

Condensed Consolidated Statements of Cash Flows for the three months ended December 31, 2002 and 2001

  

5

    

Notes to Condensed Consolidated Financial Statements

  

6

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

12

Item 3.

  

Quantitative and Qualitative Disclosures about Market Risk

  

32

Item 4.

  

Controls and Procedures

  

33

PART II—Other Information

    

Item 1.

  

Legal Proceedings

  

34

Item 2.

  

Changes in Securities and Use of Proceeds

  

34

Item 3.

  

Defaults upon Senior Securities

  

34

Item 4.

  

Submission of Matters to a Vote of Security Holders

  

34

Item 5.

  

Other Information

  

34

Item 6.

  

Exhibits and Reports on Form 8-K

  

35

Signature

  

36

Certifications

  

37

 

2


Table of Contents

 

Part I – FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

 

MICROMUSE INC.

 

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

(Unaudited)

 

    

December 31,

2002


    

September 30,

2002


 

ASSETS

                 

Current assets:

                 

Cash and cash equivalents

  

$

135,470

 

  

$

117,218

 

Short-term investments

  

 

37,031

 

  

 

42,126

 

Billed receivables, net

  

 

12,755

 

  

 

18,386

 

Prepaid expenses and other current assets

  

 

5,663

 

  

 

5,760

 

    


  


Total current assets

  

 

190,919

 

  

 

183,490

 

Property and equipment, net

  

 

8,245

 

  

 

9,534

 

Long-term investments

  

 

28,236

 

  

 

28,293

 

Goodwill and other intangible assets, net

  

 

41,369

 

  

 

40,666

 

    


  


    

$

268,769

 

  

$

261,983

 

    


  


LIABILITIES AND STOCKHOLDERS’ EQUITY

                 

Current liabilities:

                 

Accounts payable

  

$

2,853

 

  

$

2,374

 

Accrued expenses

  

 

26,086

 

  

 

25,205

 

Income taxes payable

  

 

6,723

 

  

 

6,652

 

Deferred revenue

  

 

49,515

 

  

 

36,524

 

    


  


Total current liabilities

  

 

85,177

 

  

 

70,755

 

Stockholders’ equity

                 

Preferred stock; $0.01 par value; 5,000 shares authorized no shares issued and outstanding

  

 

—  

 

  

 

—  

 

Common stock; $0.01 par value; 200,000 shares authorized; 75,279 and 75,194 shares outstanding as of December 31, 2002 and September 30, 2002, respectively

  

 

753

 

  

 

752

 

Additional paid-in capital

  

 

196,459

 

  

 

196,048

 

Treasury stock

  

 

(2,657

)

  

 

(2,657

)

Accumulated comprehensive loss

  

 

(1,622

)

  

 

(899

)

Accumulated deficit

  

 

(9,341

)

  

 

(2,016

)

    


  


Total stockholders’ equity

  

 

183,592

 

  

 

191,228

 

    


  


    

$

268,769

 

  

$

261,983

 

    


  


 

See accompanying notes to the condensed consolidated financial statements

 

3


Table of Contents

 

MICROMUSE INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

    

Three months ended December 31,


 
    

2002


    

2001


 

Revenues:

                 

License

  

$

13,423

 

  

$

23,216

 

Maintenance and services

  

 

13,674

 

  

 

16,831

 

    


  


Total revenues

  

 

27,097

 

  

 

40,047

 

    


  


Cost of revenues:

                 

License

  

 

1,076

 

  

 

1,595

 

Maintenance and services

  

 

3,289

 

  

 

5,208

 

    


  


Total cost of revenues

  

 

4,365

 

  

 

6,803

 

    


  


Gross profit

  

 

22,732

 

  

 

33,244

 

    


  


Operating expenses:

                 

Sales and marketing

  

 

14,442

 

  

 

18,085

 

Research and development

  

 

7,421

 

  

 

7,570

 

General and administrative

  

 

4,066

 

  

 

4,938

 

Amortization of goodwill and other intangible assets

  

 

1,552

 

  

 

2,767

 

Purchased in-process research and development

  

 

142

 

  

 

—  

 

Restructuring costs

  

 

3,329

 

  

 

—  

 

Executive recruiting costs

  

 

—  

 

  

 

449

 

    


  


Total operating expenses

  

 

30,952

 

  

 

33,809

 

    


  


Loss from operations

  

 

(8,220

)

  

 

(565

)

Other income, net

  

 

1,380

 

  

 

1,608

 

    


  


Income (loss) before income taxes

  

 

(6,840

)

  

 

1,043

 

Income tax provision

  

 

485

 

  

 

427

 

    


  


Net income (loss)

  

$

(7,325

)

  

$

616

 

    


  


Per share data:

                 

Basic net income (loss)

  

$

(0.10

)

  

$

0.01

 

Diluted net income (loss)

  

$

(0.10

)

  

$

0.01

 

Weighted average shares used in computing:

                 

Basic net income (loss) per share

  

 

75,241

 

  

 

74,043

 

Diluted net income (loss) per share

  

 

75,241

 

  

 

78,246

 

 

See accompanying notes to the condensed consolidated financial statements

 

4


Table of Contents

 

MICROMUSE INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

    

Three months ended December 31,


 
    

2002


    

2001


 

Cash flows from operating activities:

                 

Net income (loss)

  

$

(7,325

)

  

$

616

 

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

                 

Depreciation and amortization

  

 

3,654

 

  

 

5,066

 

Purchased in-process research & development

  

 

142

 

  

 

—  

 

Non-cash compensation expense related to restructuring

  

 

54

 

  

 

—  

 

Non-cash compensation expense related to issuance of warrant

  

 

—  

 

  

 

170

 

Tax benefit related to exercise of stock options

  

 

203

 

  

 

—  

 

Changes in operating assets and liabilities net of acquired amounts:

                 

Billed receivables, net

  

 

5,888

 

  

 

2,003

 

Prepaid expenses and other current assets

  

 

208

 

  

 

2,789

 

Accounts payable

  

 

457

 

  

 

508

 

Accrued expenses

  

 

438

 

  

 

(2,970

)

Income taxes payable

  

 

65

 

  

 

688

 

Deferred revenue

  

 

12,483

 

  

 

(621

)

    


  


Net cash provided by operating activities

  

 

16,267

 

  

 

8,249

 

    


  


Cash flows from investing activities:

                 

Capital expenditures

  

 

(216